Ticker Details
Climb Bio, Inc. Common Stock
IPO Date:	August 10, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$629.87M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.26 | 4.53%
Avg Daily Range (30 D):	$0.38 | 3.75%
Avg Daily Range (90 D):	$0.29 | 4.12%

Institutional Daily Volume
Avg Daily Volume:	.28M
Avg Daily Volume (30 D):	.78M
Avg Daily Volume (90 D):	.61M

Trade Size
Avg Trade Size (Sh.):	138
Avg Trade Size (Sh.) (30 D):	86
Avg Trade Size (Sh.) (90 D):	92

Institutional Trades
Total Institutional Trades:	98
Avg Institutional Trade:	$1.56M
Avg Institutional Trade (30 D):	$.86M
Avg Institutional Trade (90 D):	$.91M
Avg Institutional Trade Volume:	.32M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.59M
Avg Closing Trade (30 D):	$.84M
Avg Closing Trade (90 D):	$.89M
Avg Closing Volume:	399.75K

News

Apr 6, 2026 @ 5:00 PM Idiopathic Membranous Nephropathy Market is Predic... Source: Delveinsight

Feb 5, 2026 @ 12:00 PM Climb Bio to Present at Upcoming Investor Conferen... Source: Not Specified

Nov 25, 2025 @ 12:00 PM Climb Bio Reports Inducement Grant Under Nasdaq Li... Source: Carlo Tanzi, Ph.D.

Oct 17, 2025 @ 11:00 AM Climb Bio to Present Data at American Society of N... Source: Climb Bio, Inc.

Aug 25, 2025 @ 6:41 PM UPDATE – Climb Bio to Present at Upcoming S... Source: Carlo Tanzi, Ph.D.

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.2	$-.25	$-.88
Diluted EPS	$-.2	$-.25	$-.88
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-13.72M	$-17.52M	$-59.85M
Operating Income / Loss	$-15.21M	$-19.3M	$-67.88M
Cost of Revenue
Net Cash Flow	$-27.33M	$-51.54M	$-51.54M
PE Ratio